Penumbra enrolls first patient in stroke thrombectomy study

Go back to Penumbra enrolls first patient in stroke thrombectomy study
(NYSE: PEN) Delayed: 319.26 -2.91 (0.9%)
Previous Close $322.17    52 Week High $79.49 
Open $322.61    52 Week Low $40.23 
Day High $322.61    P/E N/A 
Day Low $319.18    EPS $0.00 
Volume 380,763